Clincosm LogoSign in Get a demo

A Pilot Study to Test the Acceptability and Feasibility of Relaxation Rooms to Help Reduce Occupational Stress Among Healthcare Workers

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT05134155
Collaborator
Well Living Lab, Inc. (Industry)
50
Enrollment
1
Location
9.1
Anticipated Duration (Months)
5.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Test the acceptability and feasibility of a relaxation room to reduce work stress among clinicians and collect clinician-reported outcome data after using the relaxation room.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The plan is to pilot test a relaxation room to demonstrate its acceptability and feasibility in the hospital and collect clinician-centered outcomes. This study will inform the design of a future trial using this intervention.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Pilot Study to Test the Acceptability and Feasibility of Relaxation Rooms to Help Reduce Occupational Stress Among Healthcare Workers
    Actual Study Start Date :
    Feb 26, 2022
    Anticipated Primary Completion Date :
    Dec 1, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Acceptability [12 months]

      the proportion of clinicians who found the MindBreaks room to be somewhat acceptable or acceptable

    Secondary Outcome Measures

    1. Recruitment [12 months]

      the number recruited

    2. Room Usage [12 months]

      how long participants stayed in the MindBreaks room

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Clinician at Mayo working at St. Mary's hospital or the downtown Rochester campus during the study
    Exclusion Criteria:

    • Any physical condition that might prevent them from sitting for 20-30 minutes in the room

    • Significant hearing loss that they would not be able to hear the audio stimuli

    • Significant vision loss that they would not be able to see the visual stimuli

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic in Rochester Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic
    • Well Living Lab, Inc.

    Investigators

    • Principal Investigator: Liselotte N Dyrbye, MD, MHPE, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Colin West, Professor of Medicine, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT05134155
    Other Study ID Numbers:
    • 21-002545
    First Posted:
    Nov 24, 2021
    Last Update Posted:
    Mar 14, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Occupational Stress

    Study Results

    No Results Posted as of Mar 14, 2022